Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Offit

Showing results (371-380 of 429) with videos related to

Pageof 43
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Cancer Research|July 29, 2018
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskYingchang Lu, Alicia Beeghly-Fadiel, Lang Wu, et al.
Cancer Research|December 2, 2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionAntonis C Antoniou, Jonathan Beesley, Lesley McGuffog, et al.
Plos One|August 11, 2012
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Rebecca Hein, Melanie Maranian, John L Hopper, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer riskDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Breast Cancer Research and Treatment|November 1, 2016
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3Yosr Hamdi, Penny Soucy, Karoline B Kuchenbaeker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk ScoresJulie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, et al.
Pageof 43

Showing results (371-380 of 429) with videos related to

Sort By:
Pageof 43
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 26, 2012
A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriersYuan C Ding, Lesley McGuffog, Sue Healey, et al.
Scientific Reports|June 18, 2020
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer riskJingjing Liu, Wendy J C Prager-van der Smissen, J Margriet Collée, et al.
Journal of the National Cancer Institute|July 28, 2021
Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk ScoresDaniel R Barnes, Valentina Silvestri, Goska Leslie, et al.
British Journal of Sports Medicine|November 3, 2022
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation studySuzanne C Dixon-Suen, Sarah J Lewis, Richard M Martin, et al.
Cancer Research|July 29, 2018
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer RiskYingchang Lu, Alicia Beeghly-Fadiel, Lang Wu, et al.
Cancer Research|December 2, 2010
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionAntonis C Antoniou, Jonathan Beesley, Lesley McGuffog, et al.
Plos One|August 11, 2012
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)Rebecca Hein, Melanie Maranian, John L Hopper, et al.
Medrxiv : the Preprint Server for Health Sciences|March 18, 2024
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer riskDaniel R Barnes, Jonathan P Tyrer, Joe Dennis, et al.
Breast Cancer Research and Treatment|November 1, 2016
Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3Yosr Hamdi, Penny Soucy, Karoline B Kuchenbaeker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2017
Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk ScoresJulie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, et al.
Pageof 43